Alendronate produces greater effects than raloxifene on bone density and bone turnover in postmenopausal women with low bone density: results of EFFECT (Efficacy of FOSAMAX versus EVISTA Comparison Trial) International.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples